Ozempic, Wegovy, and Mounjaro Gastroparesis (Stomach Paralysis) Lawsuit Lawyers

If you or a loved one suffered serious health complications after taking Ozempic, Wegovy, Mounjaro, or another GLP-1 medication, you may be entitled to compensation. [firm-name] represents individuals nationwide who developed gastroparesis, intestinal blockages, vision loss, or other severe injuries linked to these weight loss and diabetes drugs. Our defective drug attorneys can help you pursue justice against the manufacturers who allegedly failed to warn about these dangerous side effects.

Why Choose Parker Waichman LLP for Your Ozempic Lawsuit

Parker Waichman LLP brings over two decades of experience representing injury victims in complex pharmaceutical litigation and mass tort cases. Since our founding, our attorneys have recovered more than $2 billion in compensation for clients nationwide.

Our Pharmaceutical Litigation Experience

Our firm handles defective drug litigation and product liability cases involving major pharmaceutical manufacturers. We have the resources, knowledge, and determination to take on companies like Novo Nordisk and Eli Lilly. Our attorneys understand the complexities of pharmaceutical litigation. This includes the scientific evidence, regulatory issues, and legal strategies required to build strong cases against drug manufacturers.

Recognized Legal Excellence

• Jerrold S. Parker, founding partner, has been recognized in Best Lawyers in America for Mass Tort Litigation and Class Actions from 2010-2026
  • Martindale-Hubbell AV Preeminent Rating – the highest rating for legal ability and ethical standards
  • Five Dragon Rating from Law Dragon – representing the highest designation for litigation excellence
• Melanie H. Muhlstock, partner, has been named to The National Trial Lawyers Top 100 Trial Lawyers List annually since 2014
  • U.S. News & World Report Best Law Firms recognition for Personal Injury
  • Better Business Bureau A+ Rating since August 2021

Nationwide Representation

Parker Waichman LLP represents clients across the United States from our seven office locations in New York, New Jersey, and Florida. We can help you regardless of where you live. You do not need to travel to Pennsylvania for pretrial proceedings in the MDL. We handle everything on your behalf.

No Upfront Costs

We handle Ozempic lawsuits on a contingency fee basis. You pay no upfront costs, no retainer fees, and no hourly charges. We only receive payment if we recover compensation for you. If we do not win your case, you owe us nothing. This arrangement allows everyone to access legal representation regardless of their financial situation.

Personalized Attention

Despite handling numerous cases, we provide personalized attention to each client. We keep you informed throughout the legal process and answer your questions. Furthermore, we make sure you understand each step of your case. Our commitment extends beyond legal representation. We genuinely care about helping injury victims obtain justice and fair compensation.

Contact Parker Waichman LLP today for a free, no-obligation case evaluation. Call (516) 466-6500 or visit www.yourlawyer.com to get started.

Understanding Ozempic and GLP-1 Weight Loss Drug Litigation

Ozempic, Wegovy, Mounjaro, and related medications belong to a class of drugs called GLP-1 receptor agonists. These medications work by mimicking a hormone that regulates blood sugar and appetite. Novo Nordisk manufactures Ozempic (semaglutide), which the FDA approved in December 2017 for type 2 diabetes treatment. The company later received approval for Wegovy (also semaglutide) in June 2021 for chronic weight management in adults with obesity or overweight. Eli Lilly produces Mounjaro (tirzepatide), approved in 2022 for diabetes, and Zepbound (tirzepatide) for weight management.

Other GLP-1 medications include Rybelsus, Trulicity, Saxenda, and Victoza. While some of these drugs received FDA approval only for diabetes management, doctors frequently prescribed them off-label for weight loss. This led to widespread use among individuals seeking to shed pounds.

Thousands of patients now report they developed serious gastrointestinal injuries and vision problems after taking these medications. Lawsuits allege that Novo Nordisk and Eli Lilly knew or should have known about these severe risks. However, they failed to adequately warn doctors and patients. The litigation centers on claims of product liability, failure to warn, and negligence against the drug manufacturers.

Serious Health Complications Linked to Ozempic

Gastroparesis and Stomach Paralysis

Gastroparesis, also known as stomach paralysis, represents the most common injury reported in Ozempic lawsuits. This condition occurs when the stomach cannot empty properly. Food remains in the digestive system far longer than normal. Patients with gastroparesis experience severe nausea, persistent vomiting, and intense abdominal pain. Additionally, they feel full after eating only small amounts and suffer chronic bloating.

Gastroparesis can become a permanent, debilitating condition. It dramatically impacts quality of life. Many patients require feeding tubes to receive adequate nutrition. Others need long-term medications to manage symptoms. The condition prevents individuals from eating normally or enjoying meals with family and friends. Furthermore, it makes maintaining proper nutrition without medical intervention nearly impossible.

Additional Serious Injuries Linked to GLP-1 Medications

Some of the other side-effects and complications brought about by GLP-1 medications are:

• Intestinal Blockages and Bowel Obstructions – Many patients developed complete or partial blockages in their intestines. These obstructions required emergency surgery to prevent life-threatening complications. They can cause severe pain and inability to pass stool or gas. Without immediate treatment, dangerous complications can occur.
• Ileus and Gastric Obstruction – Ileus occurs when the intestines stop moving food through the digestive tract. This happens even without a physical blockage. The condition causes similar symptoms to bowel obstructions. It may require hospitalization and surgical intervention.
• Gallbladder Injuries – Numerous patients required gallbladder removal (cholecystectomy) after developing gallbladder disease while taking GLP-1 medications. Gallbladder problems can cause intense pain and digestive issues. If left untreated, serious complications can develop.
• NAION (Vision Loss) – Recent studies published in medical journals including JAMA Ophthalmology have identified an association between GLP-1 medications and Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION). This is a serious eye condition that can cause sudden, permanent vision loss. In June 2025, regulatory agencies including the WHO and European Medicines Agency concluded that NAION is a very rare side effect. It potentially affects up to 1 in 10,000 users. This condition occurs when blood flow to the optic nerve becomes blocked. The result can be permanent vision damage.
• Deep Vein Thrombosis (DVT) – Some patients developed blood clots in deep veins, typically in the legs. These clots can break loose and travel to the lungs. This causes potentially fatal pulmonary embolisms.
• Pulmonary Aspiration During Surgery – GLP-1 drugs slow stomach emptying. As a result, food can remain in the stomach longer than expected. During surgical procedures requiring anesthesia, this retained food can be aspirated into the lungs. This causes serious respiratory complications such as pulmonary aspiration.
• Pancreatic Cancer Concerns – Emerging research suggests a potential link between GLP-1 medications and increased pancreatic cancer risk. However, studies continue to investigate this connection.

The National Ozempic MDL Litigation

In February 2024, the Judicial Panel on Multidistrict Litigation created MDL 3094. This consolidated Ozempic and GLP-1 drug lawsuits in the U.S. District Court for the Eastern District of Pennsylvania. Judge Karen S. Marston presides over the litigation. As of August 2025, thousands of lawsuits have been filed in the MDL. Hundreds more cases are expected as injured patients continue coming forward.

A Multi-District Litigation (MDL) consolidates similar cases from across the country for pretrial proceedings. This structure increases efficiency in several ways. It allows plaintiffs to share discovery and receive consistent rulings from one judge. Additionally, it reduces litigation costs and moves cases toward resolution faster than if they proceeded separately in different courts. However, unlike a class action lawsuit, each plaintiff in an MDL maintains an individual case. Each case has its own unique value based on specific injuries and circumstances.

The central allegations in the Ozempic MDL claim that Novo Nordisk and Eli Lilly failed to adequately warn healthcare providers and patients. The warnings concerned serious gastrointestinal and vision risks associated with their GLP-1 medications. Plaintiffs assert claims including product liability, failure to warn, and negligence. The litigation alleges the manufacturers knew or should have known about these severe side effects. Despite this knowledge, they did not provide sufficient warnings on drug labels or through other communications.

Bellwether trials are expected in the coming years. These are test cases that help both sides evaluate the strength of claims and potential settlement values. These initial trials often lead to settlement negotiations. Both parties gain insight into how juries view the evidence and claims.

Who Qualifies to File an Ozempic Lawsuit?

You may qualify to file an Ozempic lawsuit if you meet the following criteria:

• Used one or more GLP-1 medications: Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, Trulicity, Saxenda, or Victoza
• Developed serious health complications: Gastroparesis, intestinal blockage, ileus, gallbladder disease requiring removal, vision loss (NAION), or other severe gastrointestinal injuries
• Required significant medical treatment: Emergency room visits, hospitalization, surgery, or ongoing medical care for your injuries
• Diagnosis timing: Your condition developed while taking the medication or within a reasonable time after stopping
• Age considerations: Generally age 75 or younger, though exceptions may apply depending on your specific circumstances
• Medication status: No longer taking the GLP-1 drug in most cases

Important Timing Considerations

The statute of limitations for filing an Ozempic lawsuit varies by state. It typically ranges from two to three years from your diagnosis date. In some cases, it runs from when you reasonably should have discovered the connection between your injury and the medication. These deadlines can be complex. Exceptions may apply in certain situations.

Acting quickly protects your legal rights. Waiting too long could result in losing your right to pursue compensation. Parker Waichman LLP offers free case evaluations to determine your eligibility. Even if you used the medication for off-label weight loss rather than diabetes treatment, you may still qualify to file a lawsuit. Your eligibility depends on your injuries and medical treatment, not the reason you were prescribed the medication.

Compensation Available in Ozempic Lawsuits

Individuals who suffered injuries from Ozempic and related GLP-1 medications may recover several types of compensation:

Compensatory Damages

• Past Medical Expenses – Reimbursement for emergency room visits, hospitalizations, surgeries, diagnostic tests, medications, and all other medical costs you already incurred treating your injuries
• Future Medical Expenses – Compensation for ongoing treatment, future surgeries, long-term medications, feeding tubes, and other medical care you will need in the future
• Lost Wages – Recovery for income you lost while unable to work due to your illness, medical appointments, hospitalizations, and recovery periods
• Diminished Earning Capacity – Compensation if your injuries prevent you from returning to your previous employment. This also applies if they reduce your ability to earn income in the future.
• Pain and Suffering – Damages for the physical pain, discomfort, and emotional distress you experienced. This includes ongoing suffering due to your injuries.
• Loss of Quality of Life – Compensation for your inability to enjoy activities you once loved. This includes being unable to eat normally or live without chronic symptoms and medical interventions.
• Loss of Consortium – Damages for the impact your injuries had on your relationships with your spouse and family members

Punitive Damages

Punitive damages may be available if evidence shows the manufacturer’s conduct was particularly egregious. Courts award punitive damages to punish wrongdoing and deter similar future misconduct. The availability of punitive damages depends on evidence showing the manufacturer knew about the risks. Despite this knowledge, they failed to provide adequate warnings.

Important Information About Case Values

No attorney can guarantee specific outcomes or settlement amounts. Each case is unique and valued individually. The value depends on the severity of injuries, extent of medical treatment, lost income, and other factors specific to your situation. As of October 2025, the Ozempic MDL litigation remains in early stages. No settlement amounts have been publicly announced. As the litigation progresses and bellwether trials occur, settlement ranges may become clearer.

How to File an Ozempic Lawsuit with Our Attorneys

Filing an Ozempic lawsuit with Parker Waichman LLP involves a straightforward process. We designed it to make pursuing your claim as simple as possible:

Step 1: Free Consultation

Contact Parker Waichman LLP by calling (516) 466-6500 or completing our online contact form. You will speak with an attorney who will discuss your case. This includes your medical history, medication use, and injuries. This consultation costs nothing and creates no obligation to hire our firm.

Step 2: Case Investigation

If you meet the eligibility criteria, our firm begins investigating your claim. We collect your medical records and documentation. Additionally, we review your medication history and timeline. We also consult with medical experts if needed. Our thorough investigation builds a strong foundation for your case.

Step 3: Filing Your Claim

We file your lawsuit and join it with MDL 3094 in the Eastern District of Pennsylvania. Our attorneys handle all legal paperwork, court filings, and procedural requirements. We keep you informed throughout the process. You do not need to travel to Pennsylvania for pretrial proceedings. We manage everything on your behalf.

Step 4: Pursuing Compensation

Your case participates in the discovery process. This is shared among all cases in the MDL to increase efficiency. We negotiate for fair settlement on your behalf. If necessary, we prepare your case for trial to pursue maximum compensation for your injuries. Throughout this process, we fight to hold the drug manufacturers accountable. We work to obtain the justice you deserve.

Don’t wait to protect your legal rights. Statute of limitations deadlines may apply to your case. Contact Parker Waichman LLP today for your free case evaluation.

Frequently Asked Questions About Ozempic Lawsuits

Contact Parker Waichman LLP Today

If you or a loved one suffered gastroparesis, intestinal blockages, vision loss, or other serious injuries after taking Ozempic, Wegovy, Mounjaro, or another GLP-1 medication, contact Parker Waichman LLP for a free case evaluation. Our attorneys represent clients nationwide in the Ozempic MDL. Our team has the experience and expertise for you to get the compensation you deserve.

Call (516) 466-6500 or visit www.yourlawyer.com to get started. Free consultation. No fees unless we win.

Office Locations:

• Port Washington, NY (Headquarters)
• Melville, NY
• New York City, NY
• Queens, NY
• Brooklyn, NY
• Bonita Springs, FL
• West Orange, NJ

Important Legal Disclaimers

Attorney Advertising: This website is designed for general information only. The information presented at this site should not be construed to be formal legal advice nor the formation of an attorney-client relationship. Past results do not guarantee future outcomes. No attorney-client relationship is formed until a retainer agreement is signed.

Medical Disclaimer: Do not stop taking any prescription medication without first consulting your physician. Stopping medication without medical supervision could have serious health consequences.

Educational Purposes: The information on this page is for educational purposes only. It should not be considered legal or medical advice. For specific legal advice about your situation, please contact an attorney. For medical advice, please consult your healthcare provider.